These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 21543927)
21. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer. Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer. Ma Z; Wang X; He J; Xia J; Li Y PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289 [TBL] [Abstract][Full Text] [Related]
23. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma. Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788 [TBL] [Abstract][Full Text] [Related]
25. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation. Dong L; Che H; Li M; Li X Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016 [TBL] [Abstract][Full Text] [Related]
26. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression. Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751 [TBL] [Abstract][Full Text] [Related]
27. Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer. Zhang L; Wang H; Tian L; Li H Tohoku J Exp Med; 2016 Jul; 239(3):165-75. PubMed ID: 27302477 [TBL] [Abstract][Full Text] [Related]
28. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer. Hu L; Liu R Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321 [TBL] [Abstract][Full Text] [Related]
29. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Hou S; Du P; Wang P; Wang C; Liu P; Liu H Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091 [TBL] [Abstract][Full Text] [Related]
30. Relations between GPR4 expression, microvascular density (MVD) and clinical pathological characteristics of patients with epithelial ovarian carcinoma (EOC). Ren J; Jin W; Gao YE; Zhang Y; Zhang X; Zhao D; Ma H; Li Z; Wang J; Xiao L; Liu R; Chen Y; Qian J; Niu L; Wei H; Liu Y Curr Pharm Des; 2014; 20(11):1904-16. PubMed ID: 23888957 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839 [TBL] [Abstract][Full Text] [Related]
33. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
34. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Li C; Li Y; Wang X; Wang Z; Cai J; Wang L; Zhao Y; Song H; Meng X; Ning X; Xu C; Lin M; Li L; Geng J Histopathology; 2012 May; 60(6):953-63. PubMed ID: 22372608 [TBL] [Abstract][Full Text] [Related]
35. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Hynninen J; Auranen A; Carpén O; Dean K; Seppänen M; Kemppainen J; Lavonius M; Lisinen I; Virtanen J; Grénman S Gynecol Oncol; 2012 Jul; 126(1):64-8. PubMed ID: 22542580 [TBL] [Abstract][Full Text] [Related]
36. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer. Xie X; Yang M; Ding Y; Yu L; Chen J Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544 [TBL] [Abstract][Full Text] [Related]
37. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941 [TBL] [Abstract][Full Text] [Related]
38. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852 [TBL] [Abstract][Full Text] [Related]
39. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer. Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869 [TBL] [Abstract][Full Text] [Related]
40. p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer. Ito T; Hamasaki M; Matsumoto S; Hiroshima K; Tsujimura T; Kawai T; Shimao Y; Marutsuka K; Moriguchi S; Maruyama R; Miyamoto S; Nabeshima K Am J Clin Pathol; 2015 Jun; 143(6):830-8. PubMed ID: 25972325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]